[1]
H. Yuseptian, Fauzar, and R. Kurniati, “Omalizumab in Reducing Exacerbation Rate and Oral Corticosteroid Burden in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis”, sjim, vol. 4, no. 1, pp. 16-29, May 2026.